These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 29113761)

  • 21. Synthesis and biological evaluation of novel 1,2,3-triazole derivatives as anti-tubercular agents.
    Aziz Ali A; Gogoi D; Chaliha AK; Buragohain AK; Trivedi P; Saikia PJ; Gehlot PS; Kumar A; Chaturvedi V; Sarma D
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3698-3703. PubMed ID: 28712709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One-pot synthesis of new triazole--Imidazo[2,1-b][1,3,4]thiadiazole hybrids via click chemistry and evaluation of their antitubercular activity.
    Ramprasad J; Nayak N; Dalimba U; Yogeeswari P; Sriram D
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4169-73. PubMed ID: 26298500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of quinoline coupled [1,2,3]-triazoles as a promising class of anti-tuberculosis agents.
    Karthik Kumar K; Prabu Seenivasan S; Kumar V; Mohan Das T
    Carbohydr Res; 2011 Oct; 346(14):2084-90. PubMed ID: 21767828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and antitubercular evaluation of novel dibenzo[b,d]thiophene tethered imidazo[1,2-a]pyridine-3-carboxamides.
    Pulipati L; Sridevi JP; Yogeeswari P; Sriram D; Kantevari S
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3135-3140. PubMed ID: 27184765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Azide-alkyne cycloaddition towards 1H-1,2,3-triazole-tethered gatifloxacin and isatin conjugates: Design, synthesis and in vitro anti-mycobacterial evaluation.
    Xu Z; Song XF; Hu YQ; Qiang M; Lv ZS
    Eur J Med Chem; 2017 Sep; 138():66-71. PubMed ID: 28646656
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel 1,2,3-triazole derivatives for use against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain.
    Boechat N; Ferreira VF; Ferreira SB; de Lourdes G Ferreira M; de C da Silva F; Bastos MM; Dos S Costa M; Lourenço MC; Pinto AC; Krettli AU; Aguiar AC; Teixeira BM; da Silva NV; Martins PR; Bezerra FA; Camilo AL; da Silva GP; Costa CC
    J Med Chem; 2011 Sep; 54(17):5988-99. PubMed ID: 21776985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, Synthesis and In vitro Antitubercular Effect of New Chalcone Derivatives Coupled with 1,2,3-Triazoles: A Computational Docking Techniques.
    Sadineni K; Reddy Basireddy S; Rao Allaka T; Yatam S; Bhoomandla S; Muvvala V; Babu Haridasyam S
    Chem Biodivers; 2024 May; 21(5):e202400389. PubMed ID: 38457745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of 1H-pyrrolo[2,3-d]pyrimidine-1,2,3-triazole derivatives as novel anti-tubercular agents.
    Shiva Raju K; AnkiReddy S; Sabitha G; Siva Krishna V; Sriram D; Bharathi Reddy K; Rao Sagurthi S
    Bioorg Med Chem Lett; 2019 Jan; 29(2):284-290. PubMed ID: 30497913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, molecular docking and anti-mycobacterial evaluation of new imidazo[1,2-a]pyridine-2-carboxamide derivatives.
    Jose G; Suresha Kumara TH; Nagendrappa G; Sowmya HB; Sriram D; Yogeeswari P; Sridevi JP; Guru Row TN; Hosamani AA; Sujan Ganapathy PS; Chandrika N; Narendra LV
    Eur J Med Chem; 2015 Jan; 89():616-27. PubMed ID: 25462270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles.
    Kamal A; Hussaini SM; Faazil S; Poornachandra Y; Narender Reddy G; Kumar CG; Rajput VS; Rani C; Sharma R; Khan IA; Jagadeesh Babu N
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6842-6. PubMed ID: 24206766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
    Gao F; Chen Z; Ma L; Fan Y; Chen L; Lu G
    Eur J Med Chem; 2019 Oct; 180():648-655. PubMed ID: 31352245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Click chemistry approach for bis-chromenyl triazole hybrids and their antitubercular activity.
    Naik RJ; Kulkarni MV; Sreedhara Ranganath Pai K; Nayak PG
    Chem Biol Drug Des; 2012 Oct; 80(4):516-23. PubMed ID: 22737986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1H-1,2,3-Triazole tethered isatin-moxifloxacin: Design, synthesis and in vitro anti-mycobacterial evaluation.
    Jiang Y; Qian A; Li Y
    Arch Pharm (Weinheim); 2019 Jul; 352(7):e1900040. PubMed ID: 31106443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and reactions of sugar azides with alkynes: synthesis of sugar triazoles as antitubercular agents.
    Singh BK; Yadav AK; Kumar B; Gaikwad A; Sinha SK; Chaturvedi V; Tripathi RP
    Carbohydr Res; 2008 May; 343(7):1153-62. PubMed ID: 18346719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorinated 1,2,4-Triazolo[1,5-a]pyrimidine-6-carboxylic acid derivatives as antimycobacterial agents.
    Abdel-Rahman HM; El-Koussi NA; Hassan HY
    Arch Pharm (Weinheim); 2009 Feb; 342(2):94-9. PubMed ID: 19173243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, tuberculosis inhibitory activity, and SAR study of N-substituted-phenyl-1,2,3-triazole derivatives.
    Costa MS; Boechat N; Rangel EA; da Silva Fde C; de Souza AM; Rodrigues CR; Castro HC; Junior IN; Lourenço MC; Wardell SM; Ferreira VF
    Bioorg Med Chem; 2006 Dec; 14(24):8644-53. PubMed ID: 16949290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents.
    Srinivasarao S; Nandikolla A; Suresh A; Ewa AK; Głogowska A; Ghosh B; Kumar BK; Murugesan S; Pulya S; Aggarwal H; Sekhar KVGC
    Bioorg Chem; 2020 Jul; 100():103955. PubMed ID: 32464405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A click chemistry approach for the synthesis of mono and bis aryloxy linked coumarinyl triazoles as anti-tubercular agents.
    Anand A; Naik RJ; Revankar HM; Kulkarni MV; Dixit SR; Joshi SD
    Eur J Med Chem; 2015 Nov; 105():194-207. PubMed ID: 26491982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological activities of triazole derivatives as inhibitors of InhA and antituberculosis agents.
    Menendez C; Gau S; Lherbet C; Rodriguez F; Inard C; Pasca MR; Baltas M
    Eur J Med Chem; 2011 Nov; 46(11):5524-31. PubMed ID: 21944473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A click chemistry approach for the synthesis of cyclic ureido tethered coumarinyl and 1-aza coumarinyl 1,2,3-triazoles as inhibitors of Mycobacterium tuberculosis H37Rv and their in silico studies.
    Khanapurmath N; Kulkarni MV; Joshi SD; Anil Kumar GN
    Bioorg Med Chem; 2019 Oct; 27(20):115054. PubMed ID: 31471101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.